Researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health have unraveled a…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna transition from…
Read More
Cancer vaccine borrows COVID immune memory to activate T cells against tumors in mice
The global landscape of immunology has been irrevocably altered by the COVID-19 pandemic, leaving behind a massive, persistent, and highly…
Read More
Hidden “immune organ” in the skull may help fight brain cancer
For decades, the central nervous system was considered an immunological sanctuary—an organ largely walled off from the rest of the…
Read More
A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative disease
The longstanding dogma that the human brain operates in total isolation from the immune system has been decisively upended. Researchers…
Read More
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health have unveiled a…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is undergoing a fundamental transformation as pharmaceutical giants Merck & Co. and Moderna move toward the…
Read More
Cancer vaccine borrows COVID immune memory to activate T cells against tumors in mice
The global landscape of immunology has been irrevocably altered by the COVID-19 pandemic, leaving behind a pervasive, population-wide archive of…
Read More
Breakthrough Human-Cell Bone Marrow Model Promises to Transform Blood Cancer Research and Cut Animal Testing
Deep within the skeletal system lies one of the human body’s most vital and industrious microenvironments: the bone marrow. Often…
Read More
Bayer Secures FDA Accelerated Approval for Hyrnuo in Frontline HER2-Mutant Non-Small Cell Lung Cancer
Bayer has achieved a significant regulatory milestone with the US Food and Drug Administration (FDA) granting accelerated approval for its…
Read More
